We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Probiotix Health Plc | AQSE:PBX | Aquis Stock Exchange | Ordinary Share | GB00BLNBFR86 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.25 | 3.00 | 6.00 | 4.50 | 3.50 | 4.25 | 18,411 | 16:29:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
ProBiotix Health plc
("ProBiotix" or the "Company")
Change of auditor
ProBiotix Health plc (AQUIS: PBX), a life sciences business developing probiotics to support cardiometabolic health, announces the appointment of Gerald Edelman as the Company's auditor. Gerald Edelman LLP will replace Gravita Audit Limited with immediate effect.
The Company's previous auditor, Gravita Audit Limited, has confirmed to the Company that it is not aware of any circumstances connected with its termination as auditor that it considers should be brought to the attention of the Board, creditors or shareholders of the Company.
For further information, please contact:
ProBiotix Health plc |
|
Steen Andersen, Chief Executive |
Contact via Walbrook below |
|
|
Peterhouse Capital Limited (Aquis Corporate Adviser and Broker) |
Tel: 020 7469 0930 |
Mark Anwyl |
|
Duncan Vasey |
|
|
|
Walbrook PR Ltd |
probiotix@walbrookpr.com |
Anna Dunphy |
Mob: 07876 741 001 |
1 Year Probiotix Health Chart |
1 Month Probiotix Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions